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Abstract
Astrocytes constitute a very heterogeneous population of cells, which regulate pH, 
extracellular levels of ions and neurotransmitters, and energy metabolism in addition 
to actively participating in neurotransmission. In situations of damage to the CNS, 
the typical response is the degree of reactive gliosis, which can form glial scars. On 
the other hand, chronic diseases such as obesity, type 2 diabetes, hypertension, and 
atherosclerosis have been causally related to low-grade chronic inflammation in vari-
ous metabolic tissues. It has been pointed out that the identification of hypothalamic 
inflammatory alterations are triggered by overnutrition, orchestrated by the hypo-
thalamic immune system, and sustained by the pathophysiology associated with the 
metabolic syndrome. We discuss here the effects of astrocytes and the main astrocyte 
mechanisms involved in the metabolic syndrome and its comorbidities.
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1. Introduction
The cases of metabolic syndrome (MetS) in adults are increasing, due to several 
factors such as aging population, physical inactivity, obesity and chronic overnutri-
tion [1]. Metabolic abnormalities are involved in the metabolic syndrome, such 
as diabetes mellitus, hypercholesterolemia and dyslipidemia, hypertension, and 
central obesity [2]. Several studies in neuroscience and immunology are linked to 
overnutrition to neuroinflammation, particularly in the hypothalamus and in the 
hippocampus, due to interaction between accelerated adiposity, hyperglycemia, and 
cognitive decline [3–5].
The primary risk of cognitive decline in both obese and hyperglycemic indi-
viduals is the systemic and chronic inflammatory component of MetS, due to 
preparation of the resident population of glial cells to establish a form of low-grade 
neuroinflammation [6].
Astrocytes are active agents of the dynamic central nervous system (CNS) 
signaling. The astrocytes participate in a variety of essential physiological processes 
in the healthy brain, such as providing structural support to neurons, participating 
in the formation and maturation of synapses, control of homeostasis of ions and 
metabolites, receptor trafficking, neurotransmitter clearance, and modulating the 
synaptic plasticity moment by moment [7]. Many studies have shown their contri-
bution to information processing and memory formation in the brain, thus pointing 
to a role for astrocytes in higher integrated brain functions [8, 9].
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A vast arsenal at the disposal of astrocytes is being defined, as in the determina-
tion of functions and mechanisms of reactive astrogliosis, cellular hypertrophy, and 
glial scar formation with preservation of the cellular domains and rearrangement of 
the tissue structure as well as contributing to specific CNS disorders and lesions [9]. 
Neuroinflammation in the enteric system occurs due to the activation of enteric glial 
cells (EGCs) which are the most abundant cells within the enteric nervous system 
(ENS). EGCs are located adjacent to the neurons within the enteric ganglia and 
along the interganglionic connections of the myenteric and submucosal plexus but 
also protrude into the extraganglionic mucosal layer [10–13]. Their morphology and 
the expression of markers such as calcium-binding protein S100 and glial fibrillary 
acidic protein (GFAP) [14] resemble central nervous system astrocytes.
The EGCs can exert immunomodulatory functions; they can secrete inflamma-
tory signaling molecules such as interleukins IL-1β and IL-6 [10, 15] as well as other 
mediators, including nerve growth factor (NGF), S-nitrosoglutathione (GSNO), 
nitric oxide (NO), and S100B [16], and express class II major histocompatibility 
(MHC) complex molecules [16, 17]. CNS astrocytes activated by inflammation are 
characterized by hypertrophy and proliferation, coupled with a positive regulation 
of the GFAP’s cytoskeleton [18], due metabolic syndrome and inflammatory condi-
tions of the intestinal disease (IBD) [19].
Many studies have shown that multiple connections between peripheral and 
cerebral changes involving inflammatory, metabolic, and neural components have 
been identified under conditions associated with obesity [20–22]. Therefore, iden-
tifying and treating these conditions is of primary importance to people worldwide. 
Obesity-related chronic inflammation provides an important link to metabolic 
derangements including insulin resistance, cognitive impairment affecting the 
hypothalamus, and other brain regions [20].
The present study was designed to discuss the effects of astrocytes and the main 
astrocyte and neuroinflammatory mechanisms involved in the metabolic syndrome 
and their comorbidities, which gave rise to the field of immunometabolism.
2. Neuroimmunologic mechanisms and role of glial cells
Until recently the CNS was considered to be immunologically privileged, since 
many antibodies and peripheral immune system cells are usually blocked through 
the blood-brain barrier (BBB), a specialized structure composed of endothelial cells 
(ECs), pericytes, astrocytes, and microglia [23]. The BBB maintains the chemical 
composition of the neuronal microenvironment, which is necessary for the proper 
functioning of neuronal circuits, synaptic transmission, synaptic remodeling, 
angiogenesis, and neurogenesis [24].
The immune system influences the functioning of BBB, which in turn affects 
the functioning of the CNS in both physiological and pathological conditions. In 
some cases, the BBB separates the CNS from the immune system; in others it acts 
as a mediator of neuroimmune interactions, and in others it may act as a target for 
immune system attacks [25]. In physiological conditions, immune cells cross the 
BBB at a very low rate, through specific interactions, promoting the endothelial 
junctions that control the flow of cells through them [26–28]. On the other hand, 
neuropathological diseases, such as Alzheimer’s disease (AD), Parkinson’s disease 
(PD), lateral amyotrophic sclerosis (LAS), multiple sclerosis (MS), and BBB 
destruction or damage, can be induced or mediated by LPS (lipopolysaccharide), 
cytokines, prostaglandins, and nitric oxide. The BBB is capable of responding to 
LPS due to the presence of Toll-like receptor 4 (TLR4) and other Toll-like receptors 
on the membranes of the BBB cells [29]. Similarly, these cells have receptors for 
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cytokines, chemokines, and other immunological molecules [30, 31]. As a result, 
the immune system is able to affect the functions of the BBB beyond those of 
disruption.
Perivascular cells (astrocytes and microglia) in addition to endothelial cells 
produce several inflammatory factors, such as the release of cytokines and chemo-
kines that affect the BBB permeability and the expression of adhesion molecules. 
Cytokines (TNF-α, IL1-β, IFN-γ) can stimulate the expression of adhesion mol-
ecules (vascular cell adhesion molecule 1 (VCAM-1) and intercellular adhesion mol-
ecule 1(ICAM-1)) in endothelial cells allowing the passage of activated leukocytes 
into the CNS [32]. Immune cell (macrophages, lymphocytes) traffic through the 
BBB should initiate or contribute to a vicious cycle resulting in progressive synaptic 
dysfunction and neuronal loss in neurodegenerative disorders [20, 24].
On the other hand, a specific subset of T cells is essential to suppress autoim-
munity and maintain immune homeostasis. T regulatory cells (Treg) have been 
characterized with important functions. Emerging evidence shows that Treg cells 
are not only important for maintaining immune balance at the periphery but also 
contribute to the self-tolerance and immune privilege in CNS [33]. Leukocyte 
extravasation requires interactions between adhesion molecules in endothelial cells 
and leukocytes. Leukocyte adhesion molecules (LAMs) expressed by ECs include 
P-selectin, E-selectin, intercellular adhesion molecule 1 (ICAM-1), and vascular cell 
adhesion molecule 1 (VCAM-1) [34]. Selectin binds to P-selectin-binding glyco-
protein (PSGL-1), while ICAM-1 and VCAM-1 bind to α4-integrins in leukocytes. 
After the initial binding event, immune cells roll along the vessel wall releasing 
chemokines that strengthen their binding interactions, promoting the state of 
neuroinflammation [35].
Neuroinflammation is recognized as a prominent feature of various patho-
logical conditions [36]. Thus, several lines of evidence strongly suggest that 
neuroinflammation is a crucial process involved in the progression of neuronal 
degeneration, a common feature observed in several neurodegenerative disorders 
such as degenerative neuropathologies [36]. In the inflammatory process, the 
main cellular events are observed, such as increased blood flow and vascular 
permeability with consequent venular dilation and recruitment of cells to the 
inflamed site. A significant role played by reactive oxygen species has been 
observed to develop inflammation, causing endothelial cell damage and increased 
microvascular permeability, chemotactic factor production, neutrophil recruit-
ment, oxidation, and lipid peroxidation [37]. Such inflammatory mediators play 
a regulatory role in the growth, differentiation, and activation of immune cells 
[38]. Glial cells (microglia, astrocytes, and oligodendrocytes) define cerebral 
homeostasis and are responsible for defense and preservation against neural tissue 
injury [14].
3. The role of astrocytes in neuroinflammation
Astrocytes are an important group of heterogeneous cells and play key roles in 
the physiology of the nervous system, including regulation of pH, extracellular lev-
els of ions and neurotransmitters, and energy metabolism. In addition, it plays an 
important role in the formation and functioning of the BBB [39] and also actively 
participates in neurotransmission [27]. In pathological situations in the CNS, the 
typical response of astrocytes is the state of reactive gliosis involving positive gene 
regulation of cytoskeletal proteins (e.g., glial fibrillary acidic protein (GFAP)) 
and corresponding to the change in morphology reaching a state of hypertrophy, 
hyperplasia, and glial scar formation [40–42].
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In addition, astrocytes play an important role in central immunity. The innate 
immune response is accurately adjusted by identifying the type of threat that is 
present. The molecular structures that are associated with threats are recognized 
by Pattern Recognition Receptors (PRRs). PRRs recognize molecular patterns 
associated with pathogens (PAMPs) are expressions such as microorganisms 
such as bacteria, viruses and viruses, and damage-associated diseases (DAMPs) 
that signal cellular damage and are therefore responsible for a state of stress or 
injury [14]. Among PRRs, one of the main classes is the family of transmembrane 
proteins of Toll-like receptors (TLRs). Generally pathogen response and tissue 
damage happen quickly, assuming some roles of the cells of the immune system, 
releasing cytokines (IL-1β, IL-6, TNF-α) and chemokines (MCP-1, CCR-2, 
COX-2), influencing other cells of the immune system (macrophages and lym-
phocytes), and modulating the BBB [14].
Among glial cells, astrocytes play a role in the release of Toll-like receptors [43]. 
Since the TLRs are expressed and detected by the binding of their binding genes, 
a signaling mediated by the myeloid differentiation gene 88 (Myd88) is initiated, 
having an activation of the nuclear transcription factor NFκB. In the activation 
of NFκB, the inflammatory process is released through the secretion of pro- 
inflammatory molecules (1β, IL-6, TNF-α, IL-12). In addition, there is no state of 
activation of astrocytes to recruit microorganisms, lymphocytes, and dendritic cells 
to the lesion site [44].
4.  Implications of metabolic syndrome in the central nervous system: 
the role of the bowel-brain axis
The increased obesity in the last 40 years is considered a consequence of the 
sedentary lifestyle and adherence to diets rich in saturated fat and refined carbohy-
drates that induce changes in the microbiota and underlying metabolic and psycho-
logical complications [45]. Bacteria, viruses, protozoa, archaea, and fungi represent 
the microorganisms that inhabit the intestinal tract of mammals, with bacteria 
composing the majority [46, 47] in concentrations between 101 to 103 cells per gram 
in the upper intestine and 1011 to 1012 cells per gram in the colon [48].
These microorganisms play a role in human physiology through various mecha-
nisms, such as the metabolism of nutrients and the regulation of immunological 
and neuroendocrine functions, as they bind to the CNS through the enteric nervous 
system (ENS) [49]. From the microbiota, the active metabolite LPS (lipopolysac-
charide), in addition to short-chain fatty acids (SCFA), from invasive and com-
mensal bacteria, respectively [50, 51], can be expressed in the intestinal lumen 
and influence the integrity of BBB [52], especially butyrate, in which it positively 
induces the expression of junction proteins, including claudin-2, occludin, cingulin, 
and occludens-1 and occludens-2 (ZO-1 and ZO-2), forming protein structures in 
the gut, like tight junction [53, 54]. These proteins form a mechanical link between 
epithelial cells and establish paracellular diffusion of fluids and solutes in the 
barrier [55]. Where high fiber and fruit meals were shown to reduce the increas-
esinduced by meals with high saturated fat and high carbohydrate content inlevels 
inflammatory response [56].
In mammals, colon epithelial cells, adipocytes, and peripheral blood mononuclear 
cells express a pair of G-protein-coupled receptors (GPR41 and GPR43) that are acti-
vated by SCFAs through the receptors on the T enteroendocrine cells [57]. They sense 
the amount of AGCC produced by bacteria in the colon and secrete the glucagon-like 
peptide 1 (GLP-1) and the tyrosine tyrosine peptide (PYY), allowing inhibition of 
intestinal motility and increased absorption of nutrients, respectively [58]. Thus, the 
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composition of the diet determines the type of nutrient that reaches the gastrointes-
tinal tract (GI) that can alter the composition of the intestinal microbiota and the 
production of metabolites to, consequently, influence intestinal permeability [59].
Bacterial products, such as LPS, can display a variety of PAMPs recognized 
by TLRs and nucleotide-binding oligomerization domain receptors (NOD) on 
macrophages and dendritic cells in the innate immune system, such as flagel-
lin, recognized by TLR5 to induce α-defensin secretion through Paneth cells, a 
NOD-dependent antimicrobial protein [60]. All TLRs recognize protein, lipid, 
or nucleotide PAMPs. TLR2, TLR4, and TLR6 recognize fungal PAMPs, while 
TLR9 and TLR11 recognize protozoan PAMPs [61]. Although TLRs can activate 
immune cell proliferation through an Akt-dependent pathway, they will all 
induce the expression and secretion of cytokines [61]. Although TLRs may 
activate immune cell proliferation via an Akt-dependent pathway, all but TLR3 
will induce the expression and secretion of tumor necrosis factor-α (TNF-α), 
interleukin 1β (IL-1β), and interferon-γ (IFN-γ), recruiting the primary myeloid 
differentiation response 88 (MYD88), which recruits the kinase family associ-
ated with the interleukin-1 receptor (IRAK), leading to phosphorylation of the 
inhibitory protein kappa B (I- kB) to induce translocation of nuclear factor kappa 
B (NF-kB) and influence the expression of inflammation [62, 63]. In addition, 
the activation of TLRs participates in the proliferation of epithelial cells and IgA 
secretion in the intestinal lumen, essential for intestinal barrier integrity and 
bacterial population balance, respectively [61]. Deregulation of these processes, 
or excessive activation of TLRs, can result in chronic inflammatory responses 
and exuberant repair [64].
In the epithelium, segmented bacterial filaments (SFB) and other commensal 
microbes activate dendritic cells (DCs) and macrophages in the lamina propria, 
inducing T helper 17 (TH17) cells through the production of interleukins IL-1β, 
IL-6, and IL-23 and helper T cells (TH1) by the possible production of interleu-
kin-12 (IL-12) [21]. TH17 cells regulate the gut microbiota community by secreting 
the IL-22-dependent antimicrobial lectin regenerating islet-derived 3 gamma 
(REGIIIγ). One of the microbial derivatives, polysaccharide A (PSA), stimulates 
intestinal epithelial cells to secrete growth factor and β transformation (TGFβ), 
inducing DCs and macrophages to secrete retinoic acid and interleukin 10 (IL-10) to 
promote activation of regulatory T cells and forkhead box P3 (FOXP3) and, subse-
quently, inactivation of TH17 and TH1 cells, in a type of negative feedback between 
the cells of defense in relation to the balance of the gut bacteria [65]. Activation 
of TLRs induces B cell-activating factor (BAFF) secretion, which differentiates B 
cells by increasing activation-induced cytidine deaminase (AID) expression and 
promotes differentiation of IgA-producing plasma cells, by maturing antibodies 
and casting in the intestinal lumen to alter the composition and function of the 
microbiota [65].
In obese individuals, due to imbalance of the microbiota (dysbiosis) and oxida-
tive stress, TLR4 is activated and recognizes the bacterial LPS and the flagellin of 
commensal bacteria, activating TLR5 for dendritic cell signaling and activation of 
innate lymphoid cells (ILCs), both processes to secrete REGIIIY [66]. ILCs commu-
nicate with the microbiota through cytokines, aryl hydrocarbon (AhR) receptors, 
and antimicrobial peptides and participate in the cross-talk of epithelial cells with 
the intestinal microbiota [67]. Divided into three groups, group ILCs (ILC1) are 
activated by interleukin-12 (IL-12) derived from myeloid cells, which in response 
secrete IFN-γ, whereas group ILCs (ILC2) interact with mast cells, eosinophils, 
basophils, and macrophages, and group 3 (ILC3) ILCs interact with cells of both 
innate and adaptive immune systems to secrete IL-22 and initiate an antimicrobial 
program along with restoration of the intestinal barrier [68].
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5. Neuroinflammation from the intestine
The gut-brain axis is composed of the central nervous system, innervated by affer-
ents and efferents of the vagus nerve and extrinsic fibers of the autonomic nervous 
system (ANS) interconnecting it to the hypothalamic-pituitary-adrenal (HPA) axis, 
in addition to the intrinsic neurons of the enteric nervous system and the intestinal 
microbiota. Intrinsic intestinal innervations connect the intestine to the brain via 
vagal and spinal fibers, whereas the brain sends efferent sympathetic and parasympa-
thetic fibers to the intestine [69, 70]. The HPA axis is part of the limbic system and is 
the main regulator of stress response and intestinal function during digestion which, 
due to the corticotrophin releasing factor (CRF) secreted by the hypothalamus, can 
influence the motility, permeability, and level of intestinal inflammation [47, 71]. 
Therefore stress and emotions can influence the microbial composition of the intes-
tine by bacterial products that gain access through the bloodstream and the postrema 
area and due to the release of glucocorticoids and/or sympathetic neurotransmitters 
that influence the physiology of the intestine and alter the habitat of the microbiota, 
such as noradrenaline, which may even influence bacterial gene expression or signal-
ing among bacteria, altering the composition and activity of the microbiota [72].
After bacterial colonization, increased production of neurotransmitters, such as 
serotonin (5-HT) and γ-aminobutyric acid (GABA), and the expression of various 
cytokines are physiological implications essential for intestinal homeostasis and 
HPA axis programming, which plays an important role in stress responses [73]. The 
attention is focused on the stress due to serotonin, which is synthesized through 
tryptophan, in enterochromaffin cells (EC), about 90%, and in autonomic nerves, 
about 10%, i.e., at the level of the gastrointestinal tract [74].
Stress, corticosterone, and inflammation are the cornerstones of the catabolism 
of L-tryptophan (TRP) to kynurenine (KYN) and, subsequently, to quinolinic acid 
(QUIN) [75, 76]. TRP catalysis occurs through the enzymes indoleamine 2,3-dioxy-
genase (IDO), kynurenine monooxygenase (KMO), and tryptophan 2,3-dioxygen-
ase (TDO), where stress results in the production of corticotropin-release hormone 
(CRH) by the hypothalamus, which induces the synthesis of adrenocorticotropic 
hormone (ACTH) by corticotrope cells in the anterior pituitary to target by blood 
the adrenal cortex and synthesize glucocorticoids for induction of TDO and activa-
tion of intracellular glucocorticoid receptors (GR) and subsequent TRP catalysis 
in KYN and kynurenic acid (KYNA) by kynurenine aminotransferase (KAT) or in 
3-hydroxyquinurenine (3OH-KYN), both with neurotoxic potential of cataboliz-
ing 5-HT in 5-hydroxyindoleacetic acid (5-HIAA) by kynurenine monooxygenase 
[77]. On the other hand, stress induced by β-adrenergic receptors on the MSA axis 
(medullary sympathetic- adrenal) activates lymphoid cells and induces the release 
of proinflammatory cytokines IL-1β, IL-6 and IFN-γ and catecholamines [76].
These events induce the barrier permeability and increase of bacterial endotoxin 
through the gut, which stimulates immune cells in the lamina propria to secrete 
proinflammatory cytokines and prostaglandins (PGE2) to communicate the brain 
via afferent nerves, compromising the intestinal barrier and creating a cycle, where 
inflammatory cytokines will activate the SAM and HPA axes, resulting in barrier 
rupture, increased endotoxin translocation, and an inflammatory and stress state 
[78]. Where, one of the causes of this translocation, from the intestinal point of 
view, concerns LPS of invasive bacteria and their arrival in the intestinal lumen, in 
which it will induce a pro-inflammatory response in lymphoid and innate immune 
cells, and subsequent release of cytokines such such as IL-1β, IL-6 and TNF-α, in 
the bloodstream to the brain, from the axis of the gut-brain, affecting BBB integ-
rity, causing a pro-inflammatory stress cycle in CNS cells inducing neuroinflamma-
tion [79] Figure 1.
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6.  Mechanisms of neuroinflammation and the process of metabolic 
syndrome
The proinflammatory cytokines (IL-1β, IL-6 and IFN-γ) and catecholamines, 
are able to induce IDO within CNS, exactly within the astrocyte and microglia, so 
the uptake and metabolism of L-tryptophan into theses cells leads to the production 
of KYNA, was report have neuroprotective actions in the CNS, but the catabolism 
of L-tryptophan in the microglia gives rise to metabolites with reactive oxidative 
properties, such as 3OH-KYN, 3-HAA and QUIN, that can be transported through 
the BBB to serve as substrates and contribute to the kinurenine pathway in the CNS, 
where macrophages and microglia represent the main sources of QUIN, a agonist on 
N glutamate receptor subtype methyl-D-aspartate (NMDA) that acts as a being able 
contribute to excitotoxicity and neurotoxicity [80, 81].
The astrocytes do not appear to have KMO, which favors the formation of 
KYNA, which after being released in the presynaptic area preferentially inhibits the 
NMDARs and α7 nicotinic acetylcholine receptors (nAChRs) in the extra-synaptic 
[81] Figure 2.
This leads to more leukocyte inflammation and infiltration at the BBB, since tight 
junction proteins, including claudins, ZO-1, and occludins, are downregulated [82]. 
Figure 1. 
Mechanisms by which the intestine is able to influence actions in the central nervous system (Fernandes, HS 
and Nunes, AKS).
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In response to inflammation, leukocyte extravasation increases with positive regulation 
of VCAM-1 and ICAM-1 [39]. Once the functional capacity of astrocytes is compro-
mised, BBB is impaired, resulting in a significant increase in BBB permeability rate, a 
promotion of leukocytes in cerebrospinal fluid (CSF), and increased immune response, 
including pathogens and toxins in the CNS. This process favors the activation of astro-
cytes and microglia, which stimulates the continuous symptoms in the CNS, including 
the hypothalamus, with consequent response to the stress of insulin symptoms, as well 
as cognitive injury [83].
Within the metabolic syndrome, diabetes mellitus involves the CNS, and 
insulin signal transduction involves the activation of phosphatidyl-3 kinase 
(PI3K) and mitogen-activated protein kinase (MAPK) pathways [84]. The insulin 
receptor (IR) has two subunits (α and β). The α-subunit is directed toward the 
extracellular medium. Insulin binding to the IR receptor promotes autophos-
phorylation of the receptor on β subunits, located within the plasma membrane. 
A phosphorylation cascade of the insulin receptor substrates (IRS) 1 to 4 is then 
followed, and PI3K is then recruited into the membrane and induces the insertion 
of the GLUT glucose transporter into the plasma membrane [85]. In addition, 
PI3K also phosphorylates AKT, which in turn phosphorylates the glycogen syn-
thase kinase 3 (GSK3) protein by inactivating it. This inactivation decreases the 
phosphorylation of Tau, which is present in neurons and has the function of stabi-
lizing the microtubules for the transport of synaptic vesicles and other cellular 
components [86]. Therefore, the neuroinflammatory process comprises several 
mechanisms through the activation of the glial cells that leads to neuronal damage 
and consequent damages to the CNS.
Figure 2. 
Mechanism of astrocytes and microglia during the metabolic syndrome. Increased BBB allows the invading cells 
of the peripheral immune system and promotes the activation of glial cells, with consequent release of cytokines. 
In parallax, description of the KYN mechanism (Fernandes, HS and Nunes, AKS).
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7. Conclusion
In metabolic syndrome and obesity-associated conditions, immune and meta-
bolic dysregulation results in chronic systemic inflammation, neuroinflammation, 
cognitive impairment, and other pathological manifestations. An understanding of 
this complex pathology requires providing new insight into the regulatory role of 
the astrocytes.
Although research to date in the fields of immunometabolism and neuroinflam-
mation has produced encouraging preliminary results, there remains a vast expanse 
of unexplored questions requiring the interdisciplinary knowledge of metabolism, 
neuroscience, and immunology.
In summary, the descriptions of this study indicate that astrocytes play an 
important role in immunity by triggering neuroinflammation mediated by meta-
bolic syndrome associated with obesity. Elucidating these mechanisms by binding 
the metabolism syndrome, inflammation, and CNS by astrocytes could generate 
potential new therapeutic targets or specific strategies to combat metabolic syn-
drome and obesity.
Abbreviation
ACTH adrenocorticotropic hormone
ANS autonomic nervous system
CNS central nervous system
DAMPs damage-associated diseases
EGCs enteric glial cells
ENS enteric nervous system
GFAP glial fibrillary acidic protein
GI gastrointestinal tract
GPR G-protein-coupled receptors
GR glucocorticoid receptors
GSNO nitrosoglutathione
I- kB inhibitory protein kappa B
IBD intestinal disease
ICAM intercellular adhesion molecules 1
ILCs innate lymphoid cells
IRS insulin receptor substrates
KMO kynurenine monooxygenase
KYN kynurenine
KYNA kynurenic acid
MAPK mitogen-activated protein kinase
MetS metabolic syndrome
MHC class II major histocompatibility
Myd88 myeloid differentiation gene 88
NF-kB nuclear factor kappa B
NGF nerve growth factor
NMDA methyl-D-aspartate
NO nitric oxide
NOD oligomerization domain receptors
PAMPs molecular patterns associated with pathogens
PRRs pattern recognition receptors
QUIN kynolinic acid
SCFA short-chain fatty acids
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SFB segmented bacterial filaments
TLR4 Toll-like receptor 4
VCAM vascular cell adhesion molecule 1
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